Inactive Instrument

News Kaya Holdings, Inc. Other OTC

Equities

KAYS

US4865672095

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05	CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Investor Ideas Potcasts: Interview with Kaya Holdings on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health	28/11	NE
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game	19/23/19	NE
Kaya Holdings, Inc. Secures Site for the Sacred Mushroom(TM) Planned Psilocybin Treatment Center	28/23/28	CI
Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22	CI
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	28/23/28	AQ
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Kaya Holdings, Inc. Auditor Raises 'Going Concern' Doubt	27/23/27	CI
Kaya : Acquisition/Asset Disposal - Form 8-K	13/23/13	PU
KAYA HOLDINGS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)	13/23/13	AQ
KAYA HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21/23/21	AQ
KAYA HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	30/23/30	AQ
Kaya Holdings, Inc. Launches Fifth Dimension Therapeutics to Seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market	25/23/25	CI
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22/22/22	AQ
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23/22/23	AQ
Kaya : to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon	03/22/03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kaya Holdings, Inc. Other OTC

Equities

KAYS

US4865672095

Summary

Filters